AbbVie at SLAS2027
Jan 30 – Feb 3, 2027 San Diego, CA ~7.6k attendees Website
AbbVie brings 3 presentations to SLAS2027 in San Diego. Its program covers plate-based proteomics for targeted protein degradation, an integrated high-throughput chemistry and AI platform for drug discovery, and modular automation for biologic formulation development.
| Organization | SLAS2027 Attendance |
|---|---|
AbbVie North Chicago, IL | |
Biopharmaceutical company developing medicines in immunology, oncology, neuroscience and eye care. | Talk Mon Feb 1 3:30–3:55pm Application of Plate-Based Proteomics to Targeted Protein Degradation Talk Tue Feb 2 10–10:25am From Data to Insights: Building an Integrated HT Chemistry and AI/ML Platform for Modern Drug Discovery Poster Tue Feb 2 2–3pm Walk-Up and Plug and Play Modular End-to-End Automation for Agile Biologic Formulation Development |
Find decision makers at AbbVie
Tell us what you sell and we’ll find the people at AbbVie most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with the Society for Laboratory Automation and Screening. Organization details are derived from SLAS’s published exhibitor list and event scheduler. Submit a correction